uploads/2017/06/Broker-Recommendations-4-1.jpg

Analysts’ Recommendations for Halliburton

By

Updated

Analysts’ recommendations for Halliburton

In this part, we’ll look at Wall Street analysts’ recommendations for Halliburton (HAL) on June 12, 2017.

Article continues below advertisement

Analysts’ rating for Halliburton

On June 12, 92% of the analysts tracking Halliburton rated it as a “buy” or some equivalent. Approximately 3% rated it as a “sell” or some equivalent, while the other 5% of the analysts rated it as a “hold.” In comparison, ~57% of the analysts tracking TechnipFMC (FTI) rated it as a “buy” or some equivalent on June 12.

Analysts’ rating changes 

From March 12, 2017, to June 12, 2017, the percentage of analysts recommending a “buy” or some equivalent for Halliburton remained unchanged at 92%. Analysts’ “hold” and “sell” recommendations also didn’t change during the same period. A year ago, ~88% of the sell-side analysts recommended a “buy” for Halliburton. Halliburton accounts for 2.4% of the iShares North American Natural Resources ETF (IGE). IGE has remained nearly unchanged in the past year—compared to a 1% rise in Halliburton’s stock price.

Analysts’ target prices

On June 12, Wall Street analysts’ mean target price for Halliburton was $62.1. Currently, Halliburton is trading at ~$45, which implies ~38% upside at its current median price. A month ago, analysts’ average target price for Halliburton was ~$62.2.

The mean target price, surveyed among sell-side analysts, for Core Laboratories (CLB) is $123.5. Currently, Core Laboratories is trading at ~$107, which implies ~16% upside at its average target price. The mean target price, surveyed among sell-side analysts, for Baker Hughes (BHI) is ~$66.8. Currently, Baker Hughes is trading at ~$57, which implies ~19% upside at its mean target price.

To learn more about the OFS industry, read The Oilfield Equipment and Services Industry: A Primer.

Advertisement

More From Market Realist